Navigation Links
Wyeth Holds Annual Meeting of Stockholders
Date:4/24/2008

In 2007, our Company again delivered solid financial performance, with worldwide net revenue increasing 10%. Effective cost management added to the bottom line as pro forma diluted earnings per share increased 12%." He attributed this performance to Wyeth's position as a leading biotechnology company, the strength of its global business and growth across all three of the Company's core businesses in 2007 - pharmaceuticals, consumer healthcare products and animal health products. Also, Wyeth's pharmaceuticals business, for the first time in the Company's history, achieved more than $1 billion in full-year net sales in each of seven major product franchises: Effexor(R), the Premarin(R) family, Enbrel(R), Prevnar(R), Protonix(R), Zosyn(R) and Wyeth Nutritionals, demonstrating the breadth and depth of Wyeth's product portfolio.

In 2007, Wyeth received both U.S. and European approvals for Torisel(R), the first targeted therapy with a proven overall survival benefit in patients with advanced renal cancer. The Company also received U.S. marketing clearance for Lybrel(R), a low-dose combination contraceptive.

Mr. Poussot noted that, within the first four months of 2008, Wyeth has received U.S. Food and Drug Administration approval for two therapies that bring unique benefits to patients. Pristiq(TM) was cleared for use in major depressive disorder, providing patients with efficacy at a once-daily dose and without the need for titration. Xyntha(TM), a recombinant factor VIII product for patients with hemophilia A, was approved for the control and prevention of bleeding episodes and surgical prophylaxis. In addition, Relistor(TM) in a subcutaneous form was approved in Canada for the treatment of opioid-induced constipation in patients with advanced illness receiving palliative care.

Also during today's meeting, Emilio Emini, Ph.D., Executive Vice President, Vaccine Research and Development at Wyeth Pharmaceuticals, and Jim Connolly, Executive Vice Preside
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
2. Wyeths Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
3. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
4. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
5. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
6. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
7. Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
10. Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
11. Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Port Richey, FL (PRWEB) , ... June 30, 2015 , ... ... use nearly doubled from 2007 to 2013 while heroin-related deaths more than tripled in ... greatest drug threat (1). Novus Medical Detox Center , a leading Florida-based drug ...
(Date:6/30/2015)... ... 30, 2015 , ... ADVOCATE, the premier provider of radiology ... exclusive billing agreements with Jackson Radiology Associates in Jackson, TN. , ... of billing process software functionality called Experience Based Technology (EBTTM). EBTTM improves ...
(Date:6/30/2015)... ... June 30, 2015 , ... On June 26, 2015, Harper’s ... listed five triggers that most people would not expect to cause acne ... The primary causes of acne are clogged pores and bacteria and each ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lakeview Health, a drug and ... size of its medical staff to further enhance its ability to treat addiction ... practitioners and physician assistants -- now totals 17, compared to 7 in 2013, ...
(Date:6/30/2015)... ... , ... Family and professional dementia caregivers are invited to ... 2015 at the Hyatt Regency Denver Tech Center from 7:30 am-4:30 pm. The ... the wife and daughter of singer Glen Campbell, who will discuss their experiences ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2
... a warning in all districts after reports from New Delhi ... the world 30 years ago, along the Bangladesh-Myanmar border. ... said border security agencies have been asked to monitor if ... of the disease. ,Local reports said the alert ...
... new initiative, Coalition for Healthy India (CHI), to improve ... latest treatments and innovation. ,"Access to ... remarkable growth," USIBC President Ron Somers said Thursday while ... of the largest US firms investing in India and ...
... choose to hit beaches during summer in the West, but experts ... it in moderation and with common sense," said Dr. Warren Heymann, ... Camden. ,If you're going to be outside, try to ... appropriate clothing," use sunscreen and reapply it every two to three ...
... large scale clinical trials in order to substantiate preliminary results. ... Inc. were a small scale study which not only looked ... also at its potential as a non-surgical penis enlargement product. ... and development firm, the penis extender was shown to correct ...
... in airports, a man infected with XDR (extensively drug resistant) ... States, underscoring how drug-resistant strains of the disease could be ... attention this story has been receiving over the past few ... the potential nightmare ahead. ,'It's the main reason ...
... CITY, June 1, 2007 (AFP) - The director of ... deaths of more than 100 patients in recent ... after two former directors of the Social Security Fund, ... Thursday in the same case of syrup contaminated with ...
Cached Medicine News:Health News:Small Pox Scare Put West Bengal on High Alert 2Health News:US, India Join Together to Improve Healthcare in India 2Health News:Sunbathers Beware of Skin Cancer, Dermatologists Warn 2Health News:Sunbathers Beware of Skin Cancer, Dermatologists Warn 3Health News:Urologists Begin Clinical Trials on Treatment of Peyronies Disease 2Health News:New Strains of TB Can Be Used as a Powerful Bioterror Weapon 2Health News:New Strains of TB Can Be Used as a Powerful Bioterror Weapon 3
(Date:6/30/2015)... Millar, Inc. , a leader in catheter-based and wireless ... Craig Thummel , President/CEO and member of the ... the Company. The Company also announced its leadership succession ... Management team as his successors. The Board of Directors ... Sales and Marketing, as President, and also a member ...
(Date:6/30/2015)... CENTER VALLEY, Pa. , June 30, 2015 ... designing and delivering innovative solutions for medical and ... it is guaranteeing next-day replacements for surgical equipment ... surgical product manufacturer to offer this type of ... an Olympus Full Service Agreement earlier this year. ...
(Date:6/30/2015)... , June 30, 2015  Ardelyx, Inc. (NASDAQ: ... gastrointestinal and metabolic diseases, today announced that the Company ... 2015, from 8:00 a.m.- 1:00 pm EDT in ... The Ardelyx senior management team will present an overview ... tenapanor, which has completed Phase 2b clinical trials for ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... - Novel, ... 15 Carrington,Laboratories, Inc. (Nasdaq: CARN ) today ... toxicology studies of its,GelVac(TM) nasal powder influenza vaccine, incorporating ... a critical step during the vaccine,development and will assess ...
... N.C., Aug. 16 Cancer patients fraught with,flare-ups ... some assistance,in the form of a new easy-to-use ... to quickly deliver pain medication. Cancer patients ... Persistent cancer pain is characterized as continuous pain,present ...
Cached Medicine Technology:Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine 2Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine 3Novel Technology Breaks Through Cancer Pain 2
... determines osmolality at room temperature with the ... get are cryoscopic artifacts due to high ... interfere with freezing point determinations. The superbly ... Vapro osmometer has a much broader range ...
Rapid assay, results in 1 hours,Range 20-800 ng/mL; sensitivity 2.5 ng/mL,Can be used for animal sera; requires extraction protocol and steroid free serum...
... IMMULITE 2000 assays are ... the IMMULITE 2000, a ... immunoassay analyzer. IMMULITE 2000 ... centralization, and a rapidly ...
... in specimen radiography. The XPERT represents a research ... of gray in every digital x-ray image, thus ... density that heretofore were lost to the human ... x 2 to 8 x 8 in size, ...
Medicine Products: